Company intelligence / Profile preview

Birzeit Pharmaceutical Company

Birzeit, West Bank, Palestinebpc.ps ↗
Ownership
Private
Employees
~170
Development stage
Other
01

Overview

Birzeit Pharmaceutical Company manufactures and distributes over 270–300 pharmaceutical products, primarily generics, across a wide range of therapeutic areas, with the majority of products already commercialized in Palestine and export markets

Therapeutic areas
Metabolic DisordersOphthalmologyInfectious DiseasesGastroenterologyPulmonologyDermatologyCardiovascularOtherNeurology
Modalities
Small moleculeBiologicProtein
Industry
Biotech
02

Drug pipeline

1 asset

Fungitrin

Unknown
03

Partnerships

Not specifically disclosed in recent public sources; has distribution and marketing relationships with local/international health organizations

Beyond the preview

Go deeper on Birzeit Pharmaceutical Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Birzeit Pharmaceutical Company.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call